KemPharm Announces Pricing of Initial Public Offering
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/17/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
- S&P 500 ends lower as investors weigh data, Middle East tensions
- SanDisk upgraded at JPMorgan after investor day; shares climb
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- BOJ eyeing September rate hike, faster pace of tightening, sources say
- Micron: New Street upgrades to buy, says memory is no longer a cyclical story
KemPharm (KMPH) IPO Opens Up 7%
April 16, 2015 10:51 AM EDTToday's IPO for KemPharm (NASDAQ: KMPH) opened for trading at $11.75 after pricing 5,090,909 shares of its common stock at a price to the public of $11.00 per share.
Cowen and Company and RBC Capital Markets are acting as joint book-running managers for the offering.... More
